Evidence map›Paper›PMID 36405341›Full record

ArticleVirus evolution2022

Fast-forwarding evolution-Accelerated adaptation in a proofreading-deficient hypermutator herpesvirus.

Na Xing, Thomas Höfler, Cari J Hearn, Mariana Nascimento, Georgina Camps Paradell, Dino P McMahon, Dusan Kunec, Nikolaus Osterrieder, Hans H Cheng, Jakob Trimpert

Abstract read
In one paragraph

Article in Virus evolution, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Na XingInstitut für Virologie, Freie Universität Berlin, Berlin 14163, Germany.
Thomas HöflerInstitut für Virologie, Freie Universität Berlin, Berlin 14163, Germany.ORCID https://orcid.org/0000-0001-7486-5582
Cari J HearnUnited States Department of Agriculture, Agricultural Research Service, US National Poultry Research Center, Avian Disease and Oncology Laboratory, East Lansing, MI 48823, USA.ORCID https://orcid.org/0000-0003-1309-4547
Mariana NascimentoInstitut für Virologie, Freie Universität Berlin, Berlin 14163, Germany.
Georgina Camps ParadellInstitut für Virologie, Freie Universität Berlin, Berlin 14163, Germany.
Dino P McMahonInstitut für Biologie, Freie Universität Berlin, Berlin 14195, Germany.
Dusan KunecInstitut für Virologie, Freie Universität Berlin, Berlin 14163, Germany.
Nikolaus OsterriederInstitut für Virologie, Freie Universität Berlin, Berlin 14163, Germany.
Hans H ChengUnited States Department of Agriculture, Agricultural Research Service, US National Poultry Research Center, Avian Disease and Oncology Laboratory, East Lansing, MI 48823, USA.
Jakob TrimpertInstitut für Virologie, Freie Universität Berlin, Berlin 14163, Germany.ORCID https://orcid.org/0000-0003-1616-0810

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Evolution relies on the availability of genetic diversity for fitness-based selection. However, most deoxyribonucleic acid (DNA) viruses employ DNA polymerases (Pol) capable of exonucleolytic proofreading to limit mutation rates during DNA replication. The relative genetic stability produced by high-fidelity genome replication can make studying DNA virus adaptation and evolution an intensive endeavor, especially in slowly replicating viruses. Here, we present a proofreading-impaired Pol mutant (Y547S) of Marek's disease virus that exhibits a hypermutator phenotype while maintaining unimpaired growth

Indexed as

adaptationDNA polymerasehypermutationMarek’s Disease Viruspolymerase mutantproofreading deficient

Identifiers

PMID36405341
PMCPMC9671156

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.